Biological Sample Collection Kits

Global Biological Sample Collection Kits Market to Reach US$13.3 Billion by 2030

The global market for Biological Sample Collection Kits estimated at US$8.8 Billion in the year 2024, is expected to reach US$13.3 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Swabs, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$3.9 Billion by the end of the analysis period. Growth in the Viral Transport Media segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.4 Billion While China is Forecast to Grow at 11.1% CAGR

The Biological Sample Collection Kits market in the U.S. is estimated at US$2.4 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 11.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Biological Sample Collection Kits Market - Key Trends & Drivers Summarized

Why Are Biological Sample Collection Kits Gaining Widespread Adoption?

Biological sample collection kits have become an essential component of modern healthcare, diagnostics, and research, facilitating the accurate and efficient collection of biological specimens such as blood, saliva, urine, and tissue. These kits play a critical role in various medical applications, including disease diagnosis, forensic analysis, genetic testing, and drug discovery. The rise in chronic and infectious diseases, including cancer, diabetes, and respiratory conditions, has driven an increased demand for high-quality sample collection kits that ensure the integrity and stability of biological specimens. The expansion of at-home diagnostic testing has further propelled the market for biological sample collection kits, allowing individuals to collect samples conveniently without visiting healthcare facilities. This shift is particularly evident in the wake of the COVID-19 pandemic, which highlighted the importance of decentralized testing and remote patient monitoring. Additionally, the growing prevalence of personalized medicine and precision diagnostics has increased the need for advanced sample collection solutions that enable comprehensive genomic and proteomic analysis, improving patient outcomes and disease prevention strategies.

How Are Technological Advancements Improving Sample Collection Kits?

Innovations in sample collection technology are significantly enhancing the efficiency, accuracy, and user-friendliness of biological sample collection kits. Manufacturers are developing kits with improved stabilization agents that preserve DNA, RNA, and protein integrity for extended periods, ensuring more reliable results for downstream analysis. Additionally, advancements in microfluidic technology and lab-on-a-chip devices are enabling the miniaturization of collection systems, reducing sample contamination risks and improving transport efficiency. Another major technological leap is the integration of smart sample collection kits with digital health platforms. These connected solutions allow real-time tracking of sample integrity, storage conditions, and transportation logistics, reducing the likelihood of errors and sample degradation. AI-driven diagnostics and automation are also playing a crucial role in optimizing sample collection, allowing for faster and more precise analysis of biological specimens. As laboratories and research facilities continue to adopt digital workflows, the demand for technologically enhanced sample collection kits is expected to rise substantially.

What Market Trends Are Driving the Growth of Biological Sample Collection Kits?

The shift toward non-invasive and minimally invasive sample collection methods is one of the most significant trends driving market growth. Saliva-based and dried blood spot collection kits are gaining traction due to their ease of use, reduced discomfort for patients, and compatibility with home-based testing solutions. These non-invasive techniques are particularly valuable in pediatric and geriatric populations, where traditional blood draws can be challenging and invasive. Another key trend shaping the market is the rising emphasis on biobanking and clinical research. The growing demand for high-quality biological samples in longitudinal studies, epidemiological research, and biomarker discovery is fostering investment in standardized and high-fidelity sample collection kits. Pharmaceutical companies, academic institutions, and contract research organizations (CROs) are increasingly relying on advanced sample collection technologies to enhance the reproducibility and scalability of their studies. Additionally, regulatory agencies are imposing stringent guidelines on sample collection and transport, prompting manufacturers to develop kits that comply with global quality standards and biosafety protocols.

What Are the Key Growth Drivers for the Biological Sample Collection Kits Market?

The growth in the Biological Sample Collection Kits market is driven by several factors, including the increasing prevalence of infectious and chronic diseases, the expansion of home-based diagnostic testing, and advancements in precision medicine. The demand for high-quality biological samples in genomics, proteomics, and liquid biopsy applications is further fueling market expansion, as researchers and clinicians seek reliable and efficient collection methods. The rise of telemedicine and decentralized clinical trials is also contributing to the increased adoption of biological sample collection kits. With more patients and researchers relying on remote sample collection, the need for kits that ensure sample stability, accurate labeling, and streamlined transportation has intensified. Additionally, the growing role of AI and automation in diagnostic testing is accelerating the development of smart sample collection solutions that integrate seamlessly with digital health ecosystems. As healthcare and research institutions continue to prioritize efficiency and accuracy, the market for biological sample collection kits is expected to experience sustained growth, transforming the landscape of diagnostics and biomedical research.

SCOPE OF STUDY:

The report analyzes the Biological Sample Collection Kits market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Swabs, Viral Transport Media, Blood Collection Kits, Urine Collection Kits, Other Product Types); Application (Diagnostics Application, Research Application); End-Use (Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare End-Use, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Abbott Molecular, Inc.
• altona Diagnostics GmbH
• Becton, Dickinson and Company
• Clinigen Limited
• CTK Biotech, Inc.
• Hardy Diagnostics
• HiMedia Laboratories Private Limited
• Laboratory Corporation of America Holdings
• Medline Industries, LP.
• Puritan Medical Products Company LLC
• Qiagen, Inc.
• Roche Diagnostics International AG
• Seegene, Inc.
• Thermo Fisher Scientific, Inc.
• Vircell SL

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.